483 Covers a Broad Gradation of Problems

  • Check with publisher
  • Published date: August 14, 2017
    • Fremont, California, United States

Overview:
How you respond to the 483 should provide the foundation for any future communication with the FDA about a particular inspection. Understanding how FDA organizes its evaluation of the 483 can facilitate the FDA’s review in your favor as it is well organized, succinct and provides proper documentation.

Why You Should Attend:
Your failure to understand and properly respond to a 483 issued to you at the conclusion of an FDA inspection may quickly lead to an administrative or a legal action that can have an immediate adverse effect on a firm’s business.

Areas Covered in the Session:
What the 483 means
How to interpret the 483 - "How bad is it?"
Managing the 483 discussion with the FDA at the conclusion of the inspection
Responding to the FDA in writing

Who Will Benefit:
Manufacturers
FDA Consultants
Legal Counsel
Regulatory Affairs Managers
Quality Assurance Staff

Speaker Profile:
Casper (Cap) Uldriks, through his firm “Encore Insight LLC,” brings over 32 years of experience from the FDA. He specialized in the FDA’s medical device program as a field investigator, served as a senior manager in the Office of Compliance and an Associate Center Director for the Center for Devices and Radiological Health.

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com

Compliance4All
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Anti-E. faecalis Therapeutic Antibody

    Anti-E. faecalis Therapeutic Antibody

    Biomedical Sciences Shirley (New York) November 20, 2017 Check with publisher

    This antibody generated to the E. faecalis antigens can potentially be used in diagnostic assays. http://www.creativebiolabs.net/Anti-E-faecalis-Therapeutic-Antibody-44542.htm

  • Clinical Trials - Medical Device FDA's Program 2017

    Clinical Trials - Medical Device FDA's Program 2017

    Biomedical Sciences Fremont (California) June 14, 2017 Check with publisher

    Overview: The topic is device clinical trials. This term refers to the use of medical products on/in humans, in order to gain useful knowledge about the product. Why should you Attend: In spite of the long experience device companies have with clinic...

  • Laboratory-Developed Tests - Medical devices 2017

    Laboratory-Developed Tests - Medical devices 2017

    Biomedical Sciences Fremont (California) June 14, 2017 Check with publisher

    Overview: This presentation will review the legal definition of medical device, and how it is applied by FDA to in vitro diagnostic tests. It will review the history of FDA interest in LDTs, and will describe the current situation with respect to Lab...